Skip to content
  • Saturday, 24 October 2026
  • 6:27 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Simcere Pharmaceutical Group Partners with Stanford Medicine to Pioneer Novel Therapies for Idiopathic Pulmonary Fibrosis
Pharmaceutical R&D

Simcere Pharmaceutical Group Partners with Stanford Medicine to Pioneer Novel Therapies for Idiopathic Pulmonary Fibrosis

Teuku Ryan Jun 16, 2026 0

Simcere Pharmaceutical Group has forged a significant research collaboration with Stanford Medicine, aiming to unlock novel therapeutic avenues for idiopathic…

Read More
Pharmaceutical R&D

Japan Approves Jascayd (nerandomilast) for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

Teuku Ryan May 19, 2026 0

Boehringer Ingelheim has achieved a significant milestone in the treatment of interstitial lung diseases with the approval of Jascayd (nerandomilast)…

Read More
TWiV 1284: Clinical update with Dr. Daniel GriffinBioMarin Pharmaceutical and Profluent Partner to Accelerate AI-Driven Enzyme Therapies in Landmark Drug Discovery CollaborationAptar Pharma and Macquarie University Partner in Three-Year Initiative to Advance Pulmonary Delivery of Biologic MedicinesBioengineered Bone Marrow-on-a-Chip Breakthrough Paves Way for Advanced Drug Screening and Space Medicine Research
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Alphabet and Meta now spend nearly as much on R&D as pharma’s 10 largest drugmakersThe human voiceEngineered Immune Receptors Offer New Hope Against Global Crop-Destroying Fungal PathogensTWiV 1291: A foot in the door for cytomegalovirus
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Alphabet and Meta now spend nearly as much on R&D as pharma’s 10 largest drugmakers
Lana Keisha Oct 24, 2026
Environmental & Analytical Chemistry
The human voice
Abdurrohim Arsyad Oct 24, 2026
Molecular & Cell Biology
Engineered Immune Receptors Offer New Hope Against Global Crop-Destroying Fungal Pathogens
Angie Faith Oct 24, 2026
Microbiology & Immunology
TWiV 1291: A foot in the door for cytomegalovirus
Lina Irawan Oct 24, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ